<DOC>
	<DOCNO>NCT00308425</DOCNO>
	<brief_summary>The primary aim study evaluate safety efficacy EC-MPS plus valsartan part intensify multifactorial intervention reduction 12-month rate transplant nephropathy compare EC-MPS plus standard practice care recipient first cadaver donor kidney transplant give CsA-ME , basiliximab , short-term steroid .</brief_summary>
	<brief_title>Safety Efficacy Enteric-coated Mycophenolate Sodium ( EC-MPS ) Plus Valsartan Patients With Kidney Transplants ( MYTHOS</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Inclusion criterion 1 . Male female patient age 18 70 year 2 . Patients receive first kidney transplant cadaver donor , schedule receive CsAME antiCD25 antibody primary immunosuppression ; 3 . Patients able receive first dose ECMPS within 48 hour graft reperfusion Exclusion criterion 1 . Multiorgan recipient ( e.g . kidney pancreas , double kidney ) previous transplant organ . 2 . Recipient kidney nonheart beating , cadaver donor age 70 year , cold ischemia time 36 hour 3 . Recipient HLAidentical donor 4 . Patients PRA level ( past current level ) high 50 % 5 . Patients know hypersensitivity ECMPS component formulation ( e.g . lactose ) . 6 . Patients thrombocytopenia ( &lt; 75,000/mm3 ) , absolute neutrophil count &lt; 1,500/mm3 , and/or leukocytopenia ( &lt; 2,500/mm3 ) , and/or hemoglobin &lt; 6 g/dL Screening Baseline . 7 . HIVpositive 8 . Positive HBsAg test donor recipient . 9 . Unstable angina , acute myocardial infarction stroke last 6 month heart failure NYHA class IIIIV hemodinamically significant valvular heart disease 10 . Liver injury indicate transaminase serum level ( ALT and/or AST ) great 2 x ULN 11 . Creatinine kinase ( CK ) level great 5 x ULN . Additional protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Renal transplantation , EC-MPS</keyword>
</DOC>